Study authors conducted a meta-analysis to compare sleep duration, sleep quality, and architecture among children and adolescents with juvenile idiopathic arthritis vs their healthy peers.
Researchers evaluated the safety and tolerability of the BNT162b2 COVID-19 vaccine in adolescents with juvenile idiopathic arthritis receiving TNF inhibitors.
Using real-world data, researchers compared the clinical findings of multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activating syndrome due to systemic juvenile idiopathic arthritis.
In an editorial piece, Roberta Berard, MD, and Michelle Batthish, MD, highlight the role of a universal access program in improving the health care quality in juvenile idiopathic arthritis.
Researchers studied the effect of lower extremity involvement on exercise, function, and quality of life in the peripheral predominant forms of juvenile idiopathic arthritis.
In a nested cohort study, researchers highlighted the value of patient-reported outcomes in the management of patients with polyarticular juvenile idiopathic arthritis.
Researchers defined and validated serum biomarker profiles to differentiate between primary hemophagocytic lymphohistiocytosis (HLH), secondary HLH, and macrophage activation syndrome associated with systemic juvenile idiopathic arthritis.
Researchers assessed the prevalence and characteristics of musculoskeletal manifestations of childhood cancers and identified the factors that differentiated them from juvenile idiopathic arthritis.
Researchers evaluated the relationship of adalimumab trough concentrations and treatment response in patients with juvenile idiopathic arthritis.
Professor A.V. Ramanan, a consultant pediatric rheumatologist and the co-author of a recent review paper, provides updates on the status of treatments for juvenile idiopathic arthritis.
